Donaldson Lufkin & Jenrette said that Pfizer (PFE) - Get Pfizer Inc. Report would replace King Pharma (KG) on its Growth & Focus list, while Allergan (AGN) - Get Allergan plc Report will replace Psinet (PSIX) on the list.
: UP to recommended list from purchase list at
Canadian National Railroad
: UP to market performer from buy at Donaldson Lufkin & Jenrette.
: UP to recommended list from purchase list at Goldman Sachs.
: DOWN to attractive from buy at
Public Service Enterprise
: DOWN to outperform from buy at
: NEW strong buy at
Credit Suisse First Boston
: NEW buy at Donaldson Lufkin & Jenrette, price target 55; NEW buy at Credit Suisse First Boston.
National Financial Services
: NEW outperform at
; price target 49.
Lehman Brothers upgraded several health management companies: